| Serial Number | 97402934 |
| Word Mark | ZEKOZY |
| Filing Date | Tuesday, May 10, 2022 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Thursday, November 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 11, 2023 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 16, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Event Date | Event Description |
| Friday, May 13, 2022 | NEW APPLICATION ENTERED |
| Monday, May 16, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 7, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, July 7, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, July 7, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, February 2, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, February 2, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, February 2, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, February 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, February 28, 2023 | ASSIGNED TO EXAMINER |
| Friday, March 3, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 22, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 11, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 11, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 6, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, November 27, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, November 27, 2023 | SOU EXTENSION 1 FILED |
| Monday, November 27, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, November 29, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 31, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 31, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, May 31, 2024 | SOU EXTENSION 2 FILED |
| Thursday, June 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 21, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 21, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 21, 2024 | SOU EXTENSION 3 FILED |
| Thursday, November 21, 2024 | SOU EXTENSION 3 GRANTED |